MedPath

Dose-dependent Effects of Second-hand Smoke on Vascular Function

Not Applicable
Completed
Conditions
Cardiovascular Disease
Interventions
Other: Respirable suspended particles (RSP) PM 2.5 dose of second-hand smoke
Registration Number
NCT01007760
Lead Sponsor
University of California, San Francisco
Brief Summary

The purpose of this study is to determine the vascular effects of brief second-hand smoke exposure on normal healthy individuals.

Detailed Description

Second-hand smoke remains a significant public health threat. Despite evidence to suggest that secondhand smoke contributes to adverse cardiovascular outcomes, little is known about the dose-dependent vascular effects of brief secondhand smoke exposure at low doses commonly encountered in the community. This study will investigate the acute vascular effects and dose-dependent biological mechanisms of secondhand smoke on endothelial function and oxidative stress.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
33
Inclusion Criteria
  • Healthy non-smoking adults
Read More
Exclusion Criteria
  • Reported Active Smoking
  • History of diabetes, hypertension, chronic respiratory disease, coronary artery disease, prior myocardial infarction or heart failure
  • Pregnancy or breastfeeding
  • Current use of prescription drugs within 14 days of trial
  • Reported significant passive smoke exposure or elevated cotinine levels
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Room airRespirable suspended particles (RSP) PM 2.5 dose of second-hand smoke-
Low dose exposure second-hand smokeRespirable suspended particles (RSP) PM 2.5 dose of second-hand smoke-
High dose exposure second-hand smokeRespirable suspended particles (RSP) PM 2.5 dose of second-hand smoke-
Primary Outcome Measures
NameTimeMethod
Brachial Artery Flow-mediated dilation (FMD)Same day - before/after exposure
Secondary Outcome Measures
NameTimeMethod
Plasma measurement of asymmetric dimethylarginine (ADMA) and Nitrotyrosine levelsSame day - before/after exposure

Trial Locations

Locations (1)

UCSF San Francisco General Hospital

🇺🇸

San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath